Current Applications and Challenges of Next-Generation Sequencing in Plasma Circulating Tumour DNA of Ovarian Cancer
Circulating tumour DNA (ctDNA) facilitates longitudinal study of the tumour genome, which, unlike tumour tissue biopsies, globally reflects intratumor and intermetastatis heterogeneity. Despite its costs, next-generation sequencing (NGS) has revolutionised the study of ctDNA, ensuring a more compreh...
Main Authors: | Ricardo Roque, Ilda Patrícia Ribeiro, Margarida Figueiredo-Dias, Charlie Gourley, Isabel Marques Carreira |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-01-01
|
Series: | Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-7737/13/2/88 |
Similar Items
-
Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer
by: Lavanya Sivapalan, et al.
Published: (2022-04-01) -
Potential of circulating tumour DNA as a biomarker in liquid biopsy
by: Dimitar Dimitrov, et al.
Published: (2023-11-01) -
Clinical Applications of Circulating Tumour Cells and Circulating Tumour DNA in Non-Small Cell Lung Cancer—An Update
by: Joanna Kapeleris, et al.
Published: (2022-03-01) -
A Review of Circulating Tumour Cell Enrichment Technologies
by: Amelia J. Rushton, et al.
Published: (2021-02-01) -
Analysis of Circulating Tumour Cells in Early-Stage Uveal Melanoma: Evaluation of Tumour Marker Expression to Increase Capture
by: Aaron B. Beasley, et al.
Published: (2021-11-01)